Press releases
NeoGenomics Reports Second Quarter 2026 Results
Jul 28, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/336/neogenomics-reports-second-quarter-2026-results
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
Jul 20, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/335/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
Jul 09, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/334/neogenomics-launches-fda-approved-pten-ihc-companion-diagnostic-for-prostate-cancer
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
Jul 07, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/333/neogenomics-to-report-second-quarter-2026-financial-results-on-july-28-2026
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
Jun 25, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/332/neogenomics-appoints-carolyn-starrett-to-its-board-of-directors
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
Jun 17, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/331/neogenomics-announces-pricing-of-offering-of-275-million-convertible-senior-notes
CTA style
Default